Big Pharmaceutical Companies, facing fewer prescriptions filled, patent expirations, and FDA rejections of new drugs: 1. They are continuing to consoldate (Roche has bid $44 billion for Genentech, Teva Pharmaceutical Industries has bid $7 billion for rival Barr Pharmaceuticals). 2. They are trying desperately...